AAIC 2025 Abstract
Validation of plasma p ‐tau217 as a Blood‐Based Biomarker for dementia diagnosis in Latin American population
By Ariel Caviedes, Felipe Cabral-Miranda, Paulina Orellana, Show 14 more authorsClaudia A. Duran-Aniotz
Study in peopleBiomarkers
Abstract
Background: Plasma biomarkers have immense potential to transform dementia diagnosis globally, with phosphorylated tau 217 ( p ‐tau217) emerging as the most accurate AT(N) biomarker for diagnosis of Alzheimer's Disease (AD).
